In 2023, a jury found that Medtronic infringed on a patent for a heart valve replacement method developed by Colibri Heart Valve.

The Co-STAR trial tested the performance of colchicine in preventing new-onset arrhythmias and subclinical leaflet thrombosis ...

Abbott is doubling down on the structural heart space as it aims to gain ground in valve replacements following the recent ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

Evidence-based recommendations on transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation. This involves implanting a replacement valve inside the faulty native valve ...

Transcatheter aortic valve implantation (TAVI) has transformed the treatment of aortic stenosis.1 A series of strategy trials comparing TAVI with surgical aortic valve replacement established TAVI as ...

Frye Regional Medical Center, a Duke LifePoint facility and Duke Health affiliate in Heart in Hickory, has successfully completed its 50th Transcatheter Aortic Valve Replacement (TAVR) procedure, ...

A transcatheter aortic valve replacement platform was approved for severe asymptomatic aortic stenosis. Edwards Lifesciences’ TAVR platform is the first to be approved in this population.

Single antiplatelet therapy reduced risk of mortality and major bleeding in patients undergoing transcatheter aortic valve replacement by half ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter aortic valve replacement (TAVR) had similar rates of death or disabling ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had an overall mortality rate of just 8.1% at one year, well below the ...

An innovative heart procedure is changing the lives of patients with aortic valve disease. It's called transcatheter aortic valve replacement — or TAVR. We're learning more with BayCare.